Welcome to ResMed.com
This area of our site caters to GPs, sleep therapists and sleep lab nurses.
Non-invasive ventilation (NIV) is an effective treatment option for hypercapnic respiratory failure in patients with a chest wall disorder.1
ResMed’s Volume-Assurance mode, iVAPS (intelligent Volume-Assured Pressure Support) not only secures target volume but also alveolar ventilation by compensating for dead space ventilation. This is particularly important as patient conditions may change during the night; for example, respiratory drive is sometimes impaired during rapid eye movement (REM) sleep or when the patient moves to a supine position.
Some ResMed ventilators also feature NIV+ trigger technology that's sensitive enough that it can detect very weak breaths, triggering the ventilator to deliver the next breath for the patient so that breathing isn't delayed.
iVAPS is available in the following ResMed device used to treat respiratory failure associated with chest wall disorders:
As an alternative, Astral™ 100 and Astral 150 can also be used for the treatment of respiratory failure associated with chest wall disorders, although these devices do not offer iVAPS.
Chest wall disorders are progressive and may require ventilator settings to be adjusted, based on how the patient's condition changes.
ResMed's range of ventilators caters to patients who are non-dependent as well as those who are dependent on ventilation. For extra versatility, ResMed ventilators offer both NIV and invasive options.
ResMed's advanced data collection capabilities (device and card data storage with high-resolution flow and pressure data, I:E ratio, synchronisation details, oximetry) and ResScan™ software provide clinicians with detailed data for troubleshooting and monitoring patient progress.
ResMed's VSync algorithm ensures synchronisation when there is changing, and occasionally, large leak.